HRT Financial’s Organogenesis Holdings ORGO Stock Holding History

HRT Financial’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-274,814	Closed	-$1.42M	–	4475
2025 Q4	$1.42M	Buy	+274,814	New	+$1.33M	﹤0.01%	1514
2025 Q1	–	Sell	-56,408	Closed	-$180K	–	3154
2024 Q4	$180K	Buy	+56,408	New	+$189K	﹤0.01%	1963
2024 Q2	–	Sell	-318,943	Closed	-$905K	–	2858
2024 Q1	$905K	Buy	+318,943	New	+$1.08M	0.01%	933
2023 Q3	–	Sell	-17,126	Closed	-$56K	–	2909
2023 Q2	$56K	Sell	17,126 -340,670	-95%	-$1.01M	﹤0.01%	2019
2023 Q1	$762K	Buy	+357,796	New	+$884K	0.01%	1094
2022 Q4	–	Sell	-129,098	Closed	-$418K	–	2956
2022 Q3	$418K	Buy	129,098 +66,432	+106%	+$300K	﹤0.01%	1769
2022 Q2	$305K	Buy	62,666 +5,289	+9%	+$32.6K	﹤0.01%	2008
2022 Q1	$437K	Buy	+57,377	New	+$444K	﹤0.01%	1942
2021 Q2	–	Sell	-35,761	Closed	-$651K	–	3335
2021 Q1	$651K	Buy	+35,761	New	+$485K	0.01%	1573
2020 Q4	–	Sell	-28,585	Closed	-$109K	–	2291
2020 Q3	$109K	Buy	+28,585	New	+$113K	﹤0.01%	1507

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

HRT Financial's ORGO Position: Q1 2026 in Review

HRT Financial sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 274,814 shares — an estimated $1.42M sold.

HRT Financial first reported a position in ORGO in Q3 2020 and held it in 10 quarters. The position peaked at $1.42M in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

HRT Financial reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 274,814 Organogenesis Holdings shares in Q1 2026, an estimated $1.42M.
HRT Financial first reported a position in Organogenesis Holdings in Q3 2020 and held it in 10 quarters.
HRT Financial's Organogenesis Holdings position peaked at $1.42M in Q4 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.